NCT05722652

Brief Summary

The goal of this study is to refine and test CONFIDENCE, a multi-component clinic-based intervention in pediatric or family practice clinical settings. Using a randomized control trial design, the investigators will assess preliminary effectiveness of the intervention to increase COVID-19 vaccine intention among parents of under-vaccinated children ages 5 to 17. Participating clinics will receive a brief intervention consisting of: (1) webinar training focused on communication with vaccine-hesitant parents, (2) parent-facing educational materials about COVID-19 vaccination, (3) support to create a personalized, poster campaign featuring providers. Clinics in the control condition will receive the intervention approximately 12 months after the clinics in the intervention condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
667

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 10, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 27, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

January 14, 2025

Status Verified

January 1, 2025

Enrollment Period

1.6 years

First QC Date

February 8, 2023

Last Update Submit

January 13, 2025

Conditions

Keywords

Vaccination hesitancy

Outcome Measures

Primary Outcomes (1)

  • COVID-19 vaccine intention

    Parent exit survey in clinics: Parents will report their intention to vaccinate their children for COVID-19. See survey question below: "Did you decide to vaccinate your child against COVID-19 today? Yes/No"

    Data collection will occur in the four weeks following implementation

Secondary Outcomes (9)

  • Feasibility: Recruitment

    End of study; approximately 15 months

  • Feasibility: Data Completeness

    End of study; approximately 15 months

  • Feasibility: Randomization

    End of study; approximately 15 months

  • Acceptability: Parents

    Four to eight weeks post implementation

  • Perceived appropriateness: Parents

    Four to eight weeks post implementation

  • +4 more secondary outcomes

Study Arms (2)

Intervention Condition

EXPERIMENTAL
Behavioral: CONFIDENCE

Waitlist Condition

ACTIVE COMPARATOR

Clinics in this condition will receive the intervention approximately 12 months after the intervention condition.

Behavioral: CONFIDENCE

Interventions

CONFIDENCEBEHAVIORAL

This clinic-based, multicomponent intervention consists of 3 parts: 1. Webinar training for clinicians and clinic staff about how to communicate with vaccine-hesitant parents 2. Parent-facing educational materials about COVID-19 vaccination 3. Support in creating a personalized poster campaign featuring providers and clinic staff sharing personal stories about COVID-19 vaccination

Intervention ConditionWaitlist Condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pediatric or family practice clinic that serves pediatric population (ages 5 to 17)
  • Affiliated with UMass Memorial Health Care and/or Baystate Health
  • Serve a patient population that is at least 30% racial/ethnic minority group members.
  • Parent/guardian (referred to as parents in this proposal) of child between ages 5 and 17
  • Able to read and write in English, Spanish, Portuguese or Vietnamese, which are the predominant languages in the target communities
  • Parent of patient at participating clinical site/child received non-urgent care visit during study period
  • Child not up-to-date for COVID-19 per current CDC guidelines at the time of enrollment.

You may not qualify if:

  • °Parent under age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMass Chan Medical School

Worcester, Massachusetts, 01605, United States

Location

Related Publications (1)

  • Ryan GW, Goulding M, Borg A, Minkah P, Beeler A, Rosal MC, Lemon SC. Development and Beta-Testing of the CONFIDENCE Intervention to Increase Pediatric COVID-19 Vaccination. J Pediatr Health Care. 2023 May-Jun;37(3):244-252. doi: 10.1016/j.pedhc.2022.11.002. Epub 2022 Nov 17.

    PMID: 36470798BACKGROUND

MeSH Terms

Conditions

Vaccination Hesitancy

Interventions

Confidence Intervals

Condition Hierarchy (Ancestors)

Vaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Statistics as TopicEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Stephenie C Lemon, PhD

    University of Massachusetts Chan Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Clinics will know if they are assigned to the intervention or control condition. However, individual participants (parents of children ages 5 to 17) will not know if their clinic is in the intervention or control condition.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The investigators will be using a cluster, randomized control trial design, in which clinics are assigned to either the intervention or control group. Clinics in the control group or "waitlist" condition, will receive the intervention approximately 12 months later.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chief of the Division of Preventive and Behavioral Medicine, Department of Population and Quantitative Health Sciences

Study Record Dates

First Submitted

February 8, 2023

First Posted

February 10, 2023

Study Start

March 27, 2023

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

January 14, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

A de-identified individual-level dataset will be made available to researchers who make a reasonable request to the principal investigator. Data will be made available upon publication of the primary outcomes manuscript.

Time Frame
Data will be available will be available upon publication of the primary outcomes manuscript from this project.
Access Criteria
Data will be made available upon reasonable request from researchers.

Locations